NeoStem, Inc.

NeoStem, Inc. (Neostem), founded in 2006, is a publicly traded biotechnology company (NASDAQ symbol NBS) headquartered in New York City and with facilities in New Jersey and California. NeoStem focuses on developing cellular therapies to repair and restore damaged human tissues, cells, and organs. In addition to developing proprietary cell therapy products, NeoStem operates as a development and manufacturing organization service provider through its subsidiary Progenitor Cell Therapy under contract to other companies, and offers adult stem cell and cord blood banking services. NeoStem’s leadership team includes Robin L. Smith, M.D., MBA, chairman and chief execultive officer; Douglas W. Losordo, M.D., FACC, FAHA, chief medical officer; and Andrew L. Pecora, M.D., FACP, chief visionary officer of NeoStem, chief medical officer of Progenitor Cell Therapy, and ...